Deaths from hunger, simple infections, rampant poverty and malaria
are an everday part of life for people living in Mali, Africa. The
hopes of using biotechnology as a way to feed the hungry failed
for several reasons, particularly from gene technology moving from
public to private ownership.
Cloning Rice Gene Provides no Relief to
the People in Mali, Africa
To many Bela people living in Mali, the cloned African gene is
thought of as a gift and to others it is looked upon as a burden.
The wild rice, Oryza longistaminata, is destroyed through the use
of chemicals by commerical farmers in Africa because of its damaging
tangles of roots and leaves. The seminomadic Bela people, on the
other hand, cherish it and use it for building shelters and as a
form of food supply during difficult times.
The Bela people expressed anger and confusion after finding out
that university officials from the United States were making profits
through licenscing one of their genes to biotechnology companies.
The Bela peole couldn't understand why it wasn't being
used to help them with providing safe water, food and clothing--things
that were needed for their everyday survivial.
Biotechnology--The Cure to the Hunger
Crisis?
Coming to the aid of world hunger has always been a staple of American
culture and agriculture. One expert agreed that analyzing how to
feed future starving generations won't help the worldwide crisis,
but biotechnology would. Pest-resistant bananas, high-yielding black-eyed
peas and millet immune to parasitic infection are examples of some
of the biotechnology products presently in the production process
for the people in Africa.
Statistics on the Lifespan in Africa
- Average lifespan is 49-years-old
- Infant mortality rate--119 per 1,000 births
- Has the highest rate of childhood mortality--2,046 per 100,000
in the year 2000
- Average daily salary for a bricklayer is $1
- Annual average salary: $250
Disease-Resistant Rice--A Breakthrough
Discovery
Researchers began to clone the disease-fighting gene known as Xa21
and believed that splicing the gene through crop biotechnology into
domestic rice could help feed the poor in Third World countries.
The Wealthy Taking Advantage of the Findings
Since biotechnology has the authority to patent genes, concerns
have been raised over the possibility of prosperous nations reaping
the benefits from the genes, without compensating the poor nations.
Patent Issues
The number of plant-related biotechnology patents issued has risen
from only 16 in 1981 to 289 in 1993 and almost 2,400 in 2003. Researchers
stated that patents cause complications and hold back research efforts.
Some universities and foundations are trying to break the patent
problems by making accesible patents to advance the biotech varieties
to the poor Third World nations.
Many Africans remain leary of biotechnology and perceive it as
another attempt by the First World to help feed the poor and will
ultimately bring more harm upon them than good.
Sacramento
Bee June 6, 2004
|